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Abstract 
Posterior capsule opacification (PCO) is a complication after cataract surgery that can disrupt 
vision. The epithelial to mesenchymal transition (EMT) of lens epithelial cells (LECs) in 
response to transforming growth factor β2 (TGFβ2) has been considered an obligatory 
mechanism for PCO. In this study, we tested the efficacy of aspirin in inhibiting the TGF2-
mediated EMT of human LECs, LECs in human lens capsular bags, and lensectomized mice. In 
human LECs, the levels of the  EMT markers α-smooth muscle actin (α-SMA) and fibronectin 
were drastically reduced by treatment with 2 mM aspirin. Aspirin also halted the EMT response 
of TGFβ2 when introduced after EMT initiation. In human capsular bags, treatment with 2 mM 
aspirin significantly suppressed posterior capsule wrinkling and the expression α-SMA in 
capsule-adherent LECs. The inhibition of TGF2-mediated EMT in human LECs was not 
dependent on Smad phosphorylation or MAPK and AKT-mediated signaling. We found that 
aspirin significantly increased the acetylation of K56 and K122 in histone H3 of human LECs. 
Chromatin immunoprecipitation assays using acetyl-H3K56 or acetyl-H3K122 antibody revealed 
that aspirin blocked the TGFβ2-induced acetylation of H3K56 and H3K122 at the promoter 
regions of ACTA2 and COL1A. After lensectomy in mice, we observed an increase in the 
proliferation and α-SMA expression of the capsule-adherent LECs, which was ameliorated by 
aspirin administration through drinking water. Taken together, our results showed that aspirin 
inhibits TGFβ2-mediated EMT of LECs, possibly from epigenetic downregulation of EMT-related 
genes.  
 
Keywords: aspirin, epithelial-mesenchymal transition, posterior capsule opacification, lens 
epithelial cells, histone acetylation 
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Abbreviations: LECs, lens epithelial cells; EMT, epithelial to mesenchymal transition; PCO, 
posterior capsule opacification; TGFβ, transforming growth factor-beta; α-SMA, α-smooth 
muscle actin; FN, fibronectin; HDAC, histone deacetylase; ChIP, chromatin immunoprecipitation  
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INTRODUCTION  
During cataract surgery, a small portion of the anterior lens capsule is excised, and the cloudy 
lens is removed and replaced with an artificial intraocular lens (IOL). During this procedure, 
efforts are made to remove epithelial cells adhering to the anterior capsule, but some cells still 
remain. These remaining lens epithelial cells (LECs) can proliferate, migrate and undergo EMT 
and cause wrinkling of the posterior capsule, ultimately resulting in posterior capsule 
opacification (PCO) [1]. PCO is one of the most common post cataract surgery complications 
that can impede vision. It is reported to occur in 20% to 40% of patients 2 to 5 years after 
surgery [2]. PCO is even more prevalent in children younger than 4 years old who undergo 
cataract surgery; the rate can reach 100% within 2 years after surgery, probably due to the high 
proliferative and migratory abilities of LECs in this population [3]. Neodymium doped: yttrium-
aluminum-garnet (Nd:YAG) laser capsulotomy is the treatment of choice for PCO [4]. However, 
Nd:YAG laser treatment can lead to macular edema, retinal tear, endophthalmitis, anterior 
uveitis and myopia [5-7]; therefore more effective methods to prevent PCO are needed. 
 
The TGFβ signaling pathway is a common driver of EMT, which is characterized by the loss of 
epithelial cell properties and the acquisition of mesenchymal cell properties [8]. TGFβ-induced 
activation of the TGFβ receptor leads to the phosphorylation of the transcription factors Smad2 
and Smad3. Phosphorylated Smad2 and Smad3 form a triad with Smad4 and translocate to the 
nucleus, where they associate and cooperate with DNA binding transcription factors to activate 
or repress target genes [9]. TGFβ2 is the predominant cytokine in the aqueous humor of the 
eye. Numerous studies support that TGFβ2 signaling plays a central role in the pathogenesis of 
PCO (reviewed in [10]). 
 
Aspirin (acetylsalicylic acid) is one of the most widely used drugs to treat pain, fever, and 
inflammation [11]. Low doses of aspirin are widely used for the treatment of acute coronary 
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diseases such as heart attacks, strokes, and thrombosis [12]. The antithrombotic effect of 
aspirin is due to inhibition of cyclooxygenases 1 and 2 (COX-1 and COX-2) via acetylation of 
serine residues 530 and 516 at the active site of the enzyme [13]. Aspirin also acetylates lysine 
residues in cellular and extracellular proteins [14-17]. A recent comprehensive proteomic study 
identified more than 12,000 lysine acetylation sites in HeLa cells that were treated with 5 mM 
aspirin for 6 h [18]. In addition, aspirin has been shown to acetylate and modify histones. For 
example, Guo et al. [19] suggested that aspirin protects against experimentally induced colon 
cancer via acetylation of histone H3 at lysine (K) residue 27. In another study, aspirin was found 
to cooperate with p300 to promote histone H3 K9 acetylation [20], and this property was 
implicated in the induction of apoptosis in cultured colorectal stem cells. Histone deacetylases 
(HDACs) reverse the aspirin-mediated lysine acetylation [14], and HDAC inhibitors cause 
cytotoxic effects from aspirin-mediated hyperacetylation of proteins [21, 22]. Whether the 
beneficial effects of aspirin intake are due to its acetylation of proteins is an active topic of 
investigation. With regard to its effect in the eye, regular intake of aspirin was found to be 
associated with an increased risk of incident neovascular AMD [23], but an earlier Physicians' 
Health Study-I showed a slightly better outcome for AMD [24]. Aspirin intake did not alter the 
progression of retinopathy [25] or open-angle glaucoma [26]. Aspirin has been shown to inhibit 
experimental cataracts through acetylation of lens proteins [27, 28]. In human trials, some 
studies have shown protective effects against cataracts [29, 30], while others did not [31]. 
Whether aspirin has any effect on PCO has not been investigated. It is known that histone 
acetylation at arginine or lysine residues is associated with the repression of EMT [32, 33]. 
Studies have shown that inhibitors of HDACs suppress EMT in epithelial cells, including LECs, 
by increasing the acetylation of histones and α-tubulin [34-36]. It has also been shown that 
acetylated α-tubulin plays an important role in microtubule stabilization and cell morphology, 
and it is profoundly decreased during TGFβ-induced EMT [37].This suggests that deacetylation 
of α-tubulin is not just a marker for EMT but also plays a direct role in controlling EMT. However, 
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the precise role of histone acetylation in the EMT of LECs, especially in the regulation of 
transcriptional factors, remains unclear. In this study we tested the hypothesis that the 
acetylation of proteins by aspirin is inhibitory against the TGFβ2-mediated EMT in LECs.  
EXPERIMENTAL  
Treatment of human LECs with TGF2 
The fetal human lens epithelial cell line (FHL124) was kindly provided by Prof. Michael 
Wormstone (School of Biological Sciences, University of East Anglia, UK, originally from Prof. 
John Reddan, Oakland University, MI). FHL124 cells were cultured as previously described [38] 
and treated with aspirin (Sigma-Aldrich, St. Louis, MO, Cat# A5376) at 2 mM for 24 h and then 
cotreated with 10 ng/ml TGFβ2 (Peprotech, Inc., Rocky Hill, NJ, Cat# 100-35B,10 ng/ml) for the 
additional indicated times. The MTT assay was used to determine the cytotoxicity of aspirin or 
cell proliferation. 
 
Measurement of aspirin in the culture medium  
To determine the effective concentration of aspirin in the cell culture medium, 2 mM aspirin was 
incubated in MEM with or without 5% FBS. After 48 h, serum albumin-bound aspirin was 
removed using Amicon Ultra-0.5 ml centrifugal filters (10,000 NMWL, UFC501024, Millipore). 
The filtrate was incubated with 1 N NaOH at 50°C for 10 min, and the volume was made up to 
200 μL with 0.02 M iron(III) chloride solution. The reaction product was measured 
spectrophotometrically at 530 nm using aspirin as the standard. 
 
Western blotting 
Total cell lysates were prepared using RIPA buffer (Thermo Fisher Scientific, Cat# 89900) 
containing a protease inhibitor (Sigma-Aldrich, Cat# P8465, 1:100 dilution) and/or phosphatase 
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inhibitor cocktail (Sigma-Aldrich, Cat# P8340, 1:100 dilution). The cells were separated into 
cytoplasmic and nuclear fractions using a NucBusterTM protein extraction kit (Novagen, San 
Diego, CA, Cat# 711833) according to the manufacturer's protocol. Total histones were 
extracted using a standard extraction kit (Abcam, Cambridge, MA, Cat# ab113476). Western 
blotting was carried out as previously described [39]. The primary antibodies (applied overnight 
at 4°C) for western blotting were as follows: α-SMA (1:5,000 dilution, Sigma-Aldrich, Cat# 
A5228), αB-crystallin (1:10,000 dilution, Developmental Studies Hybridoma Bank, University of 
Iowa, IA), fibronectin (FN, 1:200 dilution, Santa Cruz Biotechnology, Cat# sc-9068), acetyl 
histone H3K115 (1:500 dilution, Abcam , Cat# ab240888), acetyl histone H3K122 (1:1,000 
dilution, Abcam, Cat# ab33309), histone H3 (1:1,000 dilution, Cat# 9715), acetyl-histone H3K9, 
K14, K18, K56 (acetyl-histone H3 antibody sampler kit, 1:1,000 dilution, Cat# 9927), Smad2 
(1:1,000 dilution, Cat# 9339), p-Smad2 (1:1,000 dilution, Cat# 3101), Smad3 (1:1,000 dilution, 
Cat# 9523), p-Smad3 (1:1,000 dilution, Cat# 9520), Smad4 (1:500 dilution, Cat# 9515), ERK 
(1:2,000 dilution, Cat# 4695), p-ERK (1:1,000 dilution, Cat# 4370), P38 (1:2,000 dilution, Cat# 
9212), p-P38 (1:1,000 dilution, Cat# 4511), AKT (1:2,000 dilution, Cat# 9272), p-AKT (1:1,000 
dilution, Cat# 9271), acetyllysine (1:2,000 dilution, Cat# 9681), acetyl-α-tubulin (1:1,000 dilution, 
Cat# 5335), and β-actin (1:5,000 dilution, Cat# 4970). HRP-conjugated anti-rabbit IgG (1:5,000 
dilution, Cat# 7074) or anti-mouse IgG (1:5,000 dilution, Cat# 7076) (Cell Signaling Technology, 
Inc., Beverly, MA) secondary antibodies were incubated at room temperature (RT) for 1 h and 
detected with the SuperSignal West Pico or Femto Kit (Pierce Chemicals, Rockford, IL). Band 
intensities were normalized to housekeeping genes using ImageJ software and presented as 
the fold change over controls. 
 
Quantitative real‐time PCR 
Quantitative real‐time PCR was performed as previously described [39]. RNA was isolated 
using the RNeasy Plus Micro Kit (Qiagen, Valencia, CA). Two micrograms of RNA was reverse-
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transcribed to synthesize cDNA using the QuantiTect Reverse Transcription Kit (Qiagen). 
Quantitative real‐time PCR was performed with SsoAdvanced™ Universal SYBR® Green 
Supermix (Bio-Rad, Richmond, CA, USA) using an iCycler iQ5 Real-Time PCR Detection 
System (Bio-Rad). The primers used are listed in Table 1. The mRNA levels were normalized to 
GAPDH. 
 
F-actin staining 
FHL124 cells were stained with Texas Red-X phalloidin (1:40 dilution, Life Technologies) for 45 
min at 37°C for visualization of the F-actin cytoskeleton. The preparations were washed three 
times with 5% normal goat serum in PBS and mounted with Vectashield mounting medium with 
DAPI (H‐1200, Vector Laboratories  Inc., Burlingame, CA). Images were viewed using a 
confocal microscope (Zeiss confocal laser scanning microscope LSM 510). 
 
Cell migration 
FHL124 cells were scraped in a straight line with a 200 μl pipet tip, debris was washed out twice 
with PBS, and cells were photographed for the initial time point under a phase-contrast 
microscope (Day 0). After images were acquired, cells were treated with either serum-free 
medium or serum-free medium containing 2 mM aspirin for 24 h. On Day 1, TGFβ2 was added 
for an additional 24 h. After the incubation, cells were imaged in the same region (Day 2), and 
the rate of cell migration was analyzed by quantifying the total distance the cells moved from the 
edge of the scratch toward the center. 
 
Human capsular bag model to study the effect of aspirin on the EMT of LECs 
Simulated cataract operations were performed to create capsular bags from human donor 
lenses [40] that were obtained with informed consent and used in accordance with the tenets of 
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the Declaration of Helsinki. Approval for the study and experimental protocols (04/Q0102/57) 
was granted by a National Research Ethics Committee (UK). A small capsulorhexis, 
approximately 5 mm in diameter, was created in the anterior lens capsule, thus allowing access 
to the lens fiber mass, which was removed by hydroexpression. Residual lens fibers were 
removed by joint irrigation and aspiration. The product of this procedure was termed a capsular 
bag, which was then removed from the eye by dissecting it from the zonular fibers. The capsular 
bag was then secured onto a sterile 35-mm polymethylmethacrylate petri dish using eight 
entomological pins (Anglian Lepidopterist Supplies, Norfolk, UK) inserted at the edge of the 
capsule to ensure that the capsular bag maintained its shape. The capsular bags were 
maintained in either serum-free or 5% FCS-supplemented Eagle’s minimum essential medium 
(EMEM) (Sigma-Aldrich, Dorset, UK) as standard control medium. Match-paired experiments 
were performed using capsular bags prepared from the same donor. The four match-paired 
combinations tested were: SF EMEM ± 2 mM aspirin; SF EMEM supplemented with 10 ng/ml 
TGFβ ± 2 mM aspirin; 5% FCS EMEM ± 2 mM aspirin; 5% FCS EMEM supplemented with 10 
ng/ml TGFβ ± 2 mM aspirin. In all cases, 50 μg/ml gentamicin (Sigma-Aldrich) was present, and 
preparations were incubated at 35°C in a 5% CO2 atmosphere. The medium was replaced 
every 2-4 days, and ongoing observations of cell growth were performed using a Nikon phase-
contrast microscope (Nikon, Tokyo, Japan) and a digital camera (Nikon) to capture images. At 
the experimental end point, the culture medium was removed from the petri dishes, and the 
capsular bags were fixed in 4% formaldehyde (Sigma-Aldrich) for 30 min. Quantification of cell 
growth across the posterior lens capsule was performed using image analysis software 
(ImageJ, 1.48v). Capsular wrinkling/matrix contraction was assessed at the experimental 
endpoint by analyzing modified dark-field images of the central posterior capsule. Images were 
subjected to the find edges function on ImageJ. Edges associated with wrinkles appear bright 
against a dark background. The image is then subjected to thresholding, which allows 
quantification. 
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Immunofluorescence 
Fixed capsular bags were rinsed three times with PBS, followed by three washes in a solution 
containing 0.02% w/v BSA and 0.05% v/v IGEPAL (Sigma-Aldrich) in PBS. The preparations 
were permeabilized with PBS containing 0.5% v/v Triton X-100 (Sigma-Aldrich) for 30 min. 
Three additional washes with 0.02% w/v BSA and 0.05% v/v IGEPAL in PBS were performed 
before nonspecific binding sites were blocked for 1 h with normal goat serum (Sigma-Aldrich) 
diluted 1:50 in 1% w/v BSA in PBS. Primary anti-α-SMA mouse monoclonal antibody (Sigma-
Aldrich, Cat# A2547) was diluted 1:100 with 1% w/v BSA in PBS and applied for 1 h at 37°C. 
Three washes with 0.02% w/v BSA and 0.05% v/v IGEPAL in PBS were subsequently 
performed, and α-SMA was visualized using an Alexa Fluor 488-conjugated goat anti-mouse 
secondary antibody (Invitrogen, Paisley, UK, Cat# 10256302) diluted 1:100 with 1% w/v BSA in 
PBS for 1 h at 37°C. Samples were then counterstained with 4’,6-diamidino-2-phenylindole 
(DAPI; Sigma-Aldrich) to visualize the nuclei. The preparations were washed a final three times 
with 0.02% w/v BSA and 0.05% v/v IGEPAL solution, floated onto glass microscope slides and 
placed in Hydromount mounting medium (National Diagnostics, Hull, UK). Images were viewed 
using a Zeiss epifluorescence microscope and Zeiss software (Axiovision). To quantify 
transdifferentiation through α-SMA expression, captured fluorescence micrographs were 
analyzed following transformation into binary images by defined thresholding techniques using 
Adobe Photoshop to identify fluorescence. These images were then transferred to ImageJ, and 
the black area within the image was calculated. 
 
Effect of aspirin on HDAC activity 
HDAC activity was measured using a colorimetric assay kit (Biovision, Cat# K331). Briefly, the 
HDAC colorimetric substrate Ac-Lys(Ac)-pNA was incubated with either nuclear or cytoplasmic 
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extracts of cells for 1 h. Treatment with the lysine developer produces a chromophore, which 
was measured by reading the absorbance in a microplate reader at 405 nm.  
 
Proteomic characterization of histone adducts in aspirin-treated cells  
Chromatin (5 µg) was separated on a 15% SDS-PAGE gel and stained with SimplyBlue 
SafeStain (Invitrogen, Carlsbad, CA). Histone H3 was excised corresponding to the molecular 
weight of the protein and digested as previously described [41]. Histone H3 was digested with 
trypsin, and peptides were extracted as previously described [41]. The peptide mixtures were 
loaded onto a capillary reverse-phase analytical column (360 μm o.d. x 100 μm i.d.) using an 
Eksigent NanoLC Ultra HPLC and auto sampler. The analytical column was packed with 20 cm 
of C18 reverse-phase material (Jupiter, 3 μm beads, 300 Å or Aqua C18, 3 μm beads, 
Phenomenex) directly into a laser-pulled emitter tip. Peptides were gradient eluted at a flow rate 
of 500 nl/min, and the mobile phases consisted of water containing 0.1% formic acid (solvent A) 
and acetonitrile containing 0.1% formic acid (solvent B). A 90-min gradient was performed, 
consisting of the following: 0−15 min, 2% B (during sample loading); 15−60 min, 2−40% B; 
60−70 min, 40−90% B; 70–73 min, 90% B; 73–76 min, 90−2% B; and 76−90 min, 2% B (column 
re-equilibration). For select LC-MS/MS analyses, LC conditions were modified such that 
peptides were loaded at 0% B, and after sample loading, the peptide elution portion of the 
gradient consisted of 0–40% B from 15–60 min. Upon gradient elution, the peptides were mass 
analyzed on an LTQ Orbitrap Velos mass spectrometer (Thermo Scientific) equipped with a 
nanoelectrospray ionization source. The instrument was operated using a data-dependent 
method with dynamic exclusion enabled. Full-scan (m/z 300−2000) spectra were acquired with 
the Orbitrap (resolution 60,000), and the top 16 most abundant ions in each MS scan were 
selected for fragmentation in the LTQ. An isolation width of 2 m/z, activation time of 10 ms, and 
35% normalized collision energy were used to generate the MS2 spectra. Dynamic exclusion 
settings allowed for a repeat count of 2 within a repeat duration of 10 s, and the exclusion 
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duration time was set to 15 s. For identification of H3 peptides, tandem mass spectra were 
searched with Sequest (Thermo Fisher Scientific) against a human subset database created 
from the UniProtKB protein database (www.UniProt.org). Database searches were performed 
using the following variable modifications: +57.0214 (carbamidomethylation) on Cys; +15.9949 
(oxidation) on Met; and +14.0157 (methylation), +28.0313 (dimethylation), and +42.0106 
(acetylation) on Lys. The search results were assembled using Scaffold 3.0 (Proteome 
Software), and spectra of interest were inspected using Xcalibur 2.1 Qual Browser software 
(Thermo Scientific).  
 
Chromatin immunoprecipitation (ChIP) assay  
ChIP was carried out according to the manufacturer's (Invitrogen) instructions. Briefly, 5 X 106 
cells were crosslinked with 0.75% formaldehyde for 7 min and quenched with 1.25 M glycine for 
5 min. Cells were washed and suspended in NP40 lysis buffer containing protease inhibitors 
and the HDAC inhibitor sodium butyrate and then subjected to sonication (Diagenode Bioruptor, 
Diagenode Inc., Denville, NJ) for 30 min to shear chromatin to between 150-500 bp. Chromatin 
was immunoprecipitated with 2 μg of antibody (against acetylated H3K56, acetylated H3K122, 
or rabbit IgG) bound to magnetic beads (DynabeadsTM Protein A, Cat# 10001D, 
Invitrogen/Dynal, Oslo, Norway) at 4°C. The antibody and histone complex along with the 
magnetic beads were washed with RIPA buffer, the crosslinking was reversed by protease 
treatment, and the DNA was purified. Quantitative PCR was carried out for the promoter regions 
of α-SMA (ACTA2) and collagen type I (COL1A1). The primer pairs are listed in Table 1. The 
relative levels of DNA amplification were normalized to an input sample. To verify whether the 
Smad2/3/4 complex is associated with acetyl-H3K56 or H3K122, cell lysates were treated with a 
microbead-conjugated antibody to acetyl-H3K56 or H3K122 overnight at 40C. The bound 
proteins were rinsed with RIPA buffer 3 times, mixed with 1X loading dye, boiled for 5 min and 
then subjected to western blotting for Smad4. 
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Effect of aspirin on the EMT of LECs in lensectomized mice 
All animal experiments were performed in accordance with the ARVO statement for the Use of 
Animals in Ophthalmic and Vision Research and the University of Colorado IACUC guidelines. 
Lensectomy in mice was performed as previously described [42]. In the case of mice (strain 
129/Sv, 12-week-old males) receiving aspirin, the animals were orally administered 1 mg/ml 
aspirin or 0.89 mg/ml sodium salicylic acid (SA, molar equivalent to aspirin) in 25 mM sodium 
phosphate-buffered (SPB, pH 7.4) drinking water for 5 days prior to the lensectomy and for 5 
days after the procedure. The control group received 25 mM SPB alone. Mice consumed 3.5 to 
4 ml of drinking water per day. To test whether aspirin reached the lens, one lens was 
homogenized, and the homogenate was subjected to western blotting and another lens was 
fixed, sectioned and immunostained for acetyllysine. Mice were anaesthetized with 
ketamine/xylazine solution and the eyes were prepped with betadine and 1% proparacaine 
hydrochloride. The pupils were dilated using 1% tropicamide and 1% ophthalmic phenylephrine 
eye drops (1:4 ratio). A horizontal incision was made in the cornea and the anterior capsule with 
an ophthalmic knife. The lens fiber mass was gently hydrodissected with Hank’s balanced salt 
solution (BSS) and squeezed out of the eye through the corneal opening, leaving behind the 
lens capsule. The lens capsule was flushed with BSS, which was followed by injection of 
sodium hyaluronate viscoelastic material (Alcon Labs; 0.1 ml) into the empty capsular bag to 
prevent collapse of the bag. The corneal incision was sutured using 10–0 nylon suture. 
Antibiotic ointment was applied immediately after surgery and once daily until visible wound 
healing occurred. Lensectomy was carried out on day 5, and the animals were sacrificed on day 
10. The animals received aspirin or SA at the same concentration for 5 days after lensectomy. 
The eyes were fixed for 2 h in Davidson’s fixative solution and then changed to 4% 
paraformaldehyde overnight. The eyes were then paraffin embedded, sectioned and subjected 
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to immunofluorescence detection of α-SMA (1:100 dilution) and collagen type IV (1:100 dilution, 
Sigma, Cat# 9272), as previously described [43].  
 
Statistical analysis 
GraphPad Prism software version 7 (GraphPad Prism Software, Inc., San Diego, CA) was used 
for all statistical analyses. The data are expressed as the mean ± standard deviation (SD) of at 
least three independent experiments. We used Tukey's multiple comparison test for significant 
differences among treatment groups. A p value of < 0.05 was considered to be statistically 
significant. 
 
RESULTS 
Effect of aspirin on the cell viability, proliferation, and acetylation of cellular proteins  
We first determined the highest aspirin concentration that could be used with minimal toxicity to 
lens epithelial cells. FHL124 cells were treated with increasing concentrations of aspirin (0-5 
mM) for 48 h. The results showed that aspirin up to 2.5 mM for 48 h did not affect cell viability 
(Fig. 1A). We then determined whether aspirin inhibits cell proliferation. Cells were treated with 
aspirin (0-5 mM) for 24 h in the presence of 5% serum, followed by 10 ng/ml TGFβ2 treatment 
along with 0-5 mM aspirin for an additional 24 h. The results showed that aspirin up to 2.5 mM 
did not alter cell proliferation, even in the presence of TGFβ2 (Fig. 1B). We measured the 
concentration of aspirin in the cell culture medium (MEM) after 48 h of incubation to determine 
whether aspirin binds to serum albumin in the medium and reduces its effective concentration. 
Our results showed that after 48 h of incubation, there was no change in the aspirin 
concentration (Supplementary Fig. 1). Based on these results, 2 mM aspirin was used for all 
subsequent experiments. When tested at a 2 mM concentration, aspirin did not affect BrdU-
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incorporation into cells (Supplementary Fig. 2). We tested the reversibility of protein acetylation 
in cells treated with 2 mM aspirin alone for 24 h. Cells were treated with aspirin for 24 h, and the 
medium was then changed to remove the aspirin, after which the cells were incubated for an 
additional 24 h. The cells exposed to aspirin continuously for 48 h showed higher levels of 
acetylated proteins than that of the cells exposed to aspirin for 24 h (Fig. 1C). The removal of 
aspirin after 24 h led to a substantial reversal of protein acetylation. We treated cells with 2 mM 
aspirin for 24 h and then changed the medium and added TGFβ2 (10 ng/ml, with or without 
aspirin) and incubated for an additional 24 h. As shown in Fig. 1D, during the 24-h post 
incubation without aspirin, overall protein acetylation levels decreased, which were unaffected 
by the TGFβ2 treatment. 
 
Effect of aspirin on TGFβ2-induced EMT 
To determine the effect of aspirin on the TGFβ2-induced EMT of FHL124 cells, the cells were 
treated with 2 mM aspirin for 24 h, followed by 10 ng/ml TGFβ2 treatment along with 2 mM 
aspirin for an additional 24 h. The treatment of TGFβ2 for 24 h increased the expression of α-
SMA and FN (EMT makers in LECs) and αB-crystallin protein levels by 1.3-, 2.1- and 2.8-fold, 
respectively, compared to the control (no TGFβ2) (Fig. 2A). Treatment with aspirin 
significantly inhibited the TGFβ2-induced increases in α-SMA, FN and αB-crystallin. In cells 
that were treated with 2 mM aspirin for 24 h, followed by 10 ng/ml TGFβ2 treatment along with 
aspirin (2 mM) for another 6 h, aspirin reduced the mRNA levels for α-SMA, FN and αB-
crystallin that were induced by TGFβ2 (Fig. 2B), suggesting that the inhibition of EMT 
occurred at the transcriptional level. Immunofluorescence for α-SMA showed that aspirin 
suppressed TGFβ2-induced α-SMA expression (Fig. 2C). 
 
We tested whether the inhibition of EMT was due to the acetyl group or salicylic acid in aspirin. 
Aspirin significantly reduced the TGF2-induced expression of α-SMA (p<0.05), but at 
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equimolar concentrations, sodium salicylate (SA) failed to produce a similar response 
(Supplementary Fig. 3). These data indicated that the acetyl moiety is likely responsible for the 
inhibitory effect of aspirin. 
 
To determine whether aspirin inhibits stress fiber formation (through filamentous cytoskeletal 
actin assembly) during EMT, cells were stained with Texas Red-X phalloidin (Fig. 2D). 
Treatment with TGFβ2 strongly promoted stress fiber formation (F-actin staining) within 24 h, 
but aspirin robustly inhibited stress fiber formation. Since the filamentous cytoskeleton 
network regulates cell migration, we tested the effect of aspirin on cell migration. Forty-eight 
hours after a scratch was created, cells in the serum-free medium alone migrated to close the 
scratch by 15.7%. However, cells treated with TGFβ2 migrated by 60.9% within 24 h (p<0.05). 
Aspirin significantly inhibited TGFβ2-mediated cell migration (p<0.05, compared to TGFβ2, Fig. 
2E and F). 
 
To further test whether aspirin blocks the EMT effect already initiated by TGFβ2, FHL124 cells 
were first treated with 10 ng/ml TGFβ2 for 24 h. Aspirin was then added along with TGF2, and 
the cells were incubated for an additional 24 h. TGFβ2 increased the expression of α-SMA, FN 
αB-crystallin and by 1.8-, 2.4- and 2.9-fold, respectively (Fig. 3). The addition of aspirin at 24 h 
significantly inhibited the increase in α-SMA (by 1.2-fold, p<0.01) and αB-crystallin (by 2.2-fold, 
p<0.05). The increase in FN was inhibited (1.8-fold) but not significantly. 
 
Effect of aspirin in human capsular bag cultures  
The addition of TGFβ2 induces profound changes within human lens capsular bags, which 
include increased levels of transdifferentiation and matrix contraction [44]. We first assessed the 
effects of 2 mM aspirin on basal cell behavior following simulated cataract surgery. In the control 
preparations maintained in serum-free Eagle’s minimum essential medium (EMEM), cells 
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recolonized the anterior capsule and steadily covered the previously cell-free posterior capsule 
that lies within the visual axis (Fig. 4A). Treatment with aspirin did not have a profound effect on 
the anterior lens epithelium, but it significantly reduced the coverage of the central posterior 
capsule. Treatment with 10 ng/ml TGFβ2 promoted contraction of the posterior capsule, and 
coverage was possibly impaired; these findings are in agreement with previous reports [40, 45]. 
Cotreatment with TGFβ2 and aspirin resulted in significantly less cell coverage of the posterior 
lens capsule and matrix contraction. End-point evaluation of transdifferentiation using α-SMA 
immunocytochemistry demonstrated expression in cells growing on the central posterior capsule 
maintained in serum-free conditions. Treatment with 2 mM aspirin significantly suppressed this 
signal either alone or in combination with TGFβ2 (Fig. 4B).  
 
 
While these data strongly point to an ability of aspirin to counter events in PCO, we accept that 
changes to the ocular environment following surgery will occur, such that blood proteins will be 
present along with increased growth factors produced or activated within the eye. We therefore 
elected to undertake further tests to evaluate the effects of aspirin in medium supplemented with 
5% FCS (with or without TGFβ2). Supplementing the medium with 5% serum (5% FCS EMEM) 
accelerated the changes in the capsular bag, such that in 5% FCS EMEM alone, cell coverage 
of the posterior capsule was complete within 7 days. Treatment with aspirin significantly 
impaired the rate of coverage. However, aspirin failed to prevent the cell coverage of PC when 
cells were treated with TGFβ2 in serum-containing media. The addition of 10 ng/ml TGFβ2 to 
5% FCS EMEM-cultured capsular bags resulted in marked matrix contraction and reduced α-
SMA expression (Fig. 4C and D). Treatment with 2 mM aspirin did not halt matrix contraction, 
but the degree was significantly inhibited (Fig. 4C). A significant reduction in α-SMA was also 
observed both in the presence or absence of TGFβ2. These data suggest that aspirin inhibits 
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not only TGFβ2-dependent but also basal formation of myofibroblasts (Fig. 4D). Together, these 
data further support the observations that aspirin inhibits the TGFβ2-mediated EMT of LECs. 
 
Effect of aspirin on TGFβ2-mediated signaling pathways 
To determine whether aspirin blocks TGFβ2-mediated signaling in cells, we evaluated the 
canonical and noncanonical signaling pathways. Cells were treated with 2 mM aspirin for 24 h 
prior to treatment with TGFβ2 + aspirin for 0.5 or 2 h. While both Smad2 and Smad3 were 
phosphorylated by TGFβ2, aspirin did not change the phosphorylation levels upon TGFβ2 
treatment for 0.5 h (Fig. 5A). Cells were fractionated into cytoplasmic and nuclear fractions and 
phosphorylated (p) Smad levels were measured. We found that the p-Smad2 levels were 
significantly increased in both in the nuclear (p<0.001) and cytoplasmic (p<0.05) fractions upon 
TGFβ2 treatment for 2 h, and these increases were unaffected by aspirin (Fig. 5B). 
 
During EMT, activation of noncanonical TGFβ signaling through MAP kinases and PI3K/AKT 
can also regulate gene expression [46-48]. Several previous studies have shown that the 
inhibition of the noncanonical TGFβ pathway prevents the EMT response in LECs [39, 49]. 
Treatment with TGFβ2 for 0.5 h increased p-p38 MAPK or p-AKT (but not p-ERK) but aspirin 
had no effect on such phosphorylation (Fig. 5C). Together, these data suggest that aspirin does 
not block the canonical or noncanonical TGFβ2 signaling pathways during EMT in FHL124 cells. 
This led to the determination of whether the inhibition of EMT by aspirin occurred through the 
acetylation of histones.  
 
Effect of aspirin on HDAC activity and acetylation of α-tubulin 
Previous studies have shown that HDAC inhibitors block EMT [35, 50, 51]. To explore whether 
aspirin inhibits the enzyme activities of HDACs, we performed an assay that measured the 
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activities of HDACs (class I and II) in the cytoplasmic and nuclear fractions. FHL124 cells were 
first treated with 2 mM aspirin for 24 h and then with 10 ng/ml TGFβ2 for 24 h along with aspirin. 
The HDAC activity was reduced by 56% upon treatment with 20 µM trichostatin A (TSA, positive 
control). However, HDAC activity was not affected by aspirin in either the nuclear or cytoplasmic 
fractions (Fig. 6A). 
 
HDAC6 regulates the acetylation of α-tubulin (Ac-α-tubulin). Its inhibition promotes the 
acetylation of α-tubulin and inhibits TGFβ-induced EMT [37]. To explore whether aspirin 
increases the acetylation of α-tubulin, FHL124 cells were treated with aspirin for 24 h and then 
treated with TGFβ2 (10 ng/ml) along with aspirin for an additional 24 h. We found that aspirin 
did not induce the acetylation of -tubulin (Fig. 6B), thus precluding -tubulin’s acetylation as a 
possible cause for the inhibition of EMT. 
 
Effect of aspirin and TGF2 on the acetylation of proteins  
Based on the above results, we postulated that aspirin’s EMT inhibitory property could be due to 
the acetylation of cellular proteins. Cells treated with TGF2 (10 ng/ml for 24 h) in the presence 
or absence of aspirin were subjected to western blotting for acetyllysine-bearing proteins. 
Supplementary Fig. 4A demonstrates that treatment with aspirin resulted in the acetylation of 
lysine residues in a concentration-dependent manner. However, cotreatment with TGF2 did 
not further alter these levels. We treated cells with 2 mM aspirin in the presence or absence of 
TGF2 (10 ng/ml) for 24 h and fractionated the cells into nuclear and cytoplasmic fractions, 
followed by western blotting for acetyllysine-bearing proteins. Aspirin acetylated both 
cytoplasmic and nuclear proteins (Supplementary Fig. 4B), but TGF2 had no effect on 
acetylation. 
 
D
ow
nloaded from
 https://portlandpress.com
/biochem
j/article-pdf/doi/10.1042/BC
J20190540/862541/bcj-2019-0540.pdf by U
niversity of East Anglia user on 02 January 2020
Biochem
ical Journal. This is an Accepted M
anuscript. You are encouraged to use the Version of R
ecord that, w
hen published, w
ill replace this version. The m
ost up-to-date-version is available at https://doi.org/10.1042/BC
J20190540
 
 
 20 
Effect of aspirin on histone acetylation 
Posttranslational modification of histones regulates gene expression by altering the chromatin 
structure [52, 53]. Histone acetylation regulates many cellular processes, including chromatin 
dynamics and transcription, gene silencing, cell cycle progression, apoptosis, differentiation, 
DNA replication, DNA repair, nuclear import, and neuronal repression [54]. We observed that 
aspirin did not affect either TGFβ2 signaling or HDAC activity. This led us to hypothesize that 
aspirin acetylates histones, leading to alterations in EMT-related genes. To test this hypothesis, 
we analyzed histones from cells treated with aspirin via LC-MS/MS. The data shown in Table 2 
reveal acetylation of K9, K14, K27, K79, and K115 of histone H3 in control cells. In TGF2-
treated cells, we observed acetylation in all of the above lysine residues except for K115. 
Aspirin treatment (in the presence or absence of TGF2) showed acetylation of all the above 
lysine residues in addition to K56 and K122. 
.  
 
To further confirm the mass spectrometric results, we performed western blotting. Cells were 
treated with aspirin (2 mM) for 24 h and then with aspirin (2 mM) with or without TGFβ2 (10 
ng/ml) for an additional 6 h, and histones were extracted. While the levels of histones were 
unaltered by either aspirin or aspirin + TGFβ2 treatment (Fig. 7A, left panel), the western 
blotting results showed that histones H3/H2A were predominantly acetylated by aspirin, but 
TGFβ2 did not have an effect on its acetylation (Fig. 7A, right panel). We next sought to 
evaluate the site-specific acetylation marks on histone H3. The western blotting results showed 
that treatment with TGFβ2 alone does not affect the acetylation levels of any of the lysine 
residues tested. However, treatment with aspirin strongly increased the acetylation of K56 and 
K122 (in the presence or absence of TGFβ2), but not other lysine residues (Fig. 7B). These 
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data suggest that aspirin acetylates discrete lysine residues on histone H3, which may play an 
underlying role in the inhibition of EMT in FHL124 cells. 
 
Aspirin-mediated acetylation of H3K56 and H3K122 at the promoter region of EMT-
associated genes 
To determine whether aspirin-mediated acetylation of K56 and K122 is associated with EMT 
gene regulation, we performed ChIP assays. The ChIP assay results showed that there were 
significantly elevated levels of acetylation of H3K56 and H3K122 at the promoter regions of 
ACTA2 and COL1A in TGFβ2-treated cells compared to controls (Fig. 8A and B). Interestingly, 
even though aspirin globally enhanced acetylation at H3K56 and H3K122, it significantly 
(p<0.001) reduced the TGFβ2-mediated enhancement of acetylation at the promoter regions of 
ACTA2 and COL1A1. This decreased acetylation is consistent with the decreased EMT gene 
expression we observed in aspirin-treated cells (Fig. 2B). In control experiments in which naive 
rabbit IgG was used, there was very low amplification for ACTA2 and no amplification for 
COL1A1. These results led us to hypothesize that aspirin reduces the binding of transcription 
factors such as Smads to the promoter region of EMT-related genes and consequently inhibits 
EMT of LECs. 
 
Coimmunoprecipitations were performed to confirm that the Smad2/3/4 complex is associated 
with acetylated H3K56 and H3K122. Co-IPs indicated that the Smad complex could be pulled 
down by antibodies against either acH3K56 or acH3K122 (Fig. 8C). In both acH3K56 and 
acH3K122 immunoprecipitated samples, Smad4 levels were significantly (p<0.01) higher in the 
TGFβ2-treated cells compared to those in untreated or aspirin-treated control cells. The Smad4 
levels were significantly (p<0.01) reduced in samples immunoprecipitated with anti-acH3K122 
antibody in TGFβ2 + aspirin-treated cells. Such an inhibition was not observed in samples 
immunoprecipitated with anti-acH3K56 antibody, although the trend was similar to that of 
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acH3K122 (Fig. 8D). These results suggested that aspirin inhibits TGFβ2-mediated EMT of 
LECs by blocking Smad4 binding to the promoter region of EMT genes. 
. 
 
Effect of aspirin on the EMT of LECs in lensectomized mice 
We evaluated the effect of aspirin on the EMT of capsule-adherent LECs in lensectomized mice. 
Oral administration of aspirin to mice increased the acetylation of proteins of the lens and LECs 
(Fig. 9A and B). Mice were pretreated with aspirin for 5 days, followed by lensectomy. After 5 
days, mice were sacrificed, and the eyes were fixed and immunostained for α-SMA and 
collagen IV (a marker of the lens capsule). The immunohistochemical images indicated that 
LECs in lensectomized mice proliferated and expressed α-SMA, whereas aspirin treatment 
prevented both α-SMA expression and cell proliferation (Fig. 9C). We next determined whether 
the observed effects were due to salicylate, a product of aspirin. Both buffer (control) and SA-
treated mouse LECs had higher α-SMA levels and LEC proliferation compared to aspirin-treated 
controls. These data indicated that aspirin treatment strongly inhibits the EMT response in LECs 
after lensectomy through the acetylation of proteins 
 
DISCUSSION 
In this study, we evaluated whether aspirin can block the TGF2-mediated EMT response in 
LECs. This was based on the ability of HDAC inhibitors to prevent histone deacetylation and 
blockade of TGFβ2-mediated EMT of LECs [35, 51]. The major finding of our study is that 
aspirin inhibits TGFβ2-mediated EMT of LECs in vitro, ex vivo, and in lensectomized mice, 
possibly through acetylation of histone H3 K56 and K122. 
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We found that treatment with aspirin resulted in the acetylation of a number of cellular proteins 
in LECs. Interestingly, as we increased the aspirin concentration from 0 to 2 mM for cell 
treatment, the extent of acetylation increased in the same proteins but not in new proteins. This 
suggests that aspirin targets specific proteins in cells that are incrementally acetylated with 
increasing concentrations of aspirin. Similar observations have been made in other cells [55, 56]. 
Why aspirin-mediated acetylation is specific to some proteins requires further investigation. 
 
A previous study reported that the aberrant induction of cyclooxygenase-2 (COX-2) plays a role 
in TGFβ/Smad3-mediated EMT in human breast cancer cells [57]. It has also been reported that 
the upregulation of COX-2 and PI3K/AKT phosphorylation promotes EMT in hepatocellular 
carcinoma cells [58]. Based on these reports, we considered the possibility that aspirin 
inactivated COX-2 in LECs, resulting in the inhibition of TGFβ2-mediated EMT. A previous study 
has shown that COX-2 is present in canine lens epithelial cells and that treatment with COX-2 
inhibitors can block LEC proliferation [59], and another study showed decreased PCO in dogs 
upon treatment with COX-2 inhibitors, which was ascribed to induction of apoptosis in LECs 
[60]. Thus, it was possible that aspirin inhibited EMT in LECs through inhibition of cell migration 
and blockade of COX-2. However, it is unlikely under these conditions because aspirin at 2 mM 
(used in most experiments) did not inhibit proliferation or reduce the viability of LECs. 
Nonetheless, we cannot rule out COX-2-mediated effects of aspirin on the observed inhibition of 
lens epithelial cell proliferation in lensectomized mice. Whether aspirin affects other signaling 
mechanisms related to cell proliferation and fiber cell differentiation needs to be investigated in 
future studies. 
 
The fact that SA was unable to exhibit similar effects as aspirin clearly implicates acetylation by 
aspirin as the cause for EMT inhibition. The aspirin concentration we used to obtain the 
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inhibitory effect was 2 mM. At concentrations below 2 mM, aspirin failed to show inhibitory 
effects. The fact that aspirin acetylates the same proteins but to a higher extent when used in 
increasing concentrations suggests that there could be an acetylation threshold for the inhibition 
of EMT. What is striking is that aspirin’s uninterrupted presence is required for protein 
acetylation. When removed for 24 h, the majority of acetylated proteins lost their acetylation, 
suggesting the presence of robust deacetylation mechanisms in FHL124 cells. In fact, we have 
previously observed that FHL124 cells contain SIRT3 and SIRT5, which could deacetylate 
proteins [61]. Surprisingly, when aspirin was removed from cells during TGFβ2 treatment, there 
was no further increase in α-SMA expression, suggesting that the EMT inhibitory response 
persisted after the removal of aspirin for at least 24 h. 
 
One possibility for the inhibition of TGFβ2-mediated EMT by aspirin could be that aspirin 
reacted directly with TGFβ2 and inactivated it. Aspirin spontaneously acetylates proteins upon 
incubation with proteins [55]. Therefore, it was reasonable to assume that TGFβ2 was 
acetylated by aspirin in the culture medium. However, we found that at the concentration of 
aspirin (2 mM) and TGFβ2 (10 ng/ml) used, the TGFβ2-mediated signal transduction was 
similar in the presence or absence of aspirin. Thus, the observed inhibitory effects of aspirin 
were not due to a direct reaction of aspirin with TGFβ2. We also considered the possibility that 
inhibition of EMT by aspirin could be due to acetylation of Smads. However, several previous 
studies have shown that acetylation of Smads promotes their nuclear translocation and 
transcriptional activity [62-64]. These observations suggest that the acetylation of Smads may 
not have contributed to the inhibition of TGFβ2-mediated EMT by aspirin. The downregulation of 
αB-crystallin by aspirin could have also contributed to the inhibition of EMT, as we have 
previously shown that αB-crystallin binds to Smads and Snail and translocates to the nucleus 
during the TGFβ2-mediated EMT of LECs [42]. Such binding could have stabilized the 
transcription factors and allowed them to bind to DNA and promote EMT.   
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Several studies have shown that HDAC-mediated epigenetic mechanisms are involved in the 
EMT response in renal epithelial cells [50] and hepatocytes [65]. In particular, trichostatin A 
(TSA), a class I and II HDAC inhibitor, inhibited the TGFβ2-induced EMT of LECs [34, 35, 51]. 
However, the epigenetic mechanism by which HDAC inhibitors block the TGFβ2-mediated EMT 
of LECs is unclear. We reasoned that aspirin could inactivate HDACs and thereby inhibit 
TGFβ2-mediated EMT of LECs, similar to HDAC inhibitors. However, we found that aspirin did 
not inactivate HDACs in LECs. Further, previous studies have shown that TGFβ1-induced EMT 
is regulated by HDAC6-dependent deacetylation of α-tubulin in immortalized mammary 
epithelial cells [37] and human lung adenocarcinoma cells [36]. However, TGFβ2 did not 
deacetylate α-tubulin, and aspirin did not increase the acetylation of tubulin in LECs. Together, 
these observations ruled out a role for HDACs in aspirin’s inhibition of EMT of LECs. 
 
One major finding in our study is that aspirin increased the acetylation of K56 and K122 on 
histone H3 in the presence or absence of TGFβ2. Past studies on histone modification have 
focused mainly on the acetylation of histone tails. However, we found aspirin-mediated 
acetylation at K56 and K122, which are in the globular domain of H3. The modification of 
histones can affect two of their properties: the DNA binding affinity and the recruitment of 
nonhistone proteins [66, 67]. The lateral side of histones regulates transcriptional activity [68]. 
Interestingly, aspirin-mediated acetylated K56 and K122 are on the lateral surface of histone H3. 
This modification of histones is important for RNA transcription, but the exact mechanisms are 
unclear. A study showed that acetylation of the lateral surface of histone H3 reduces the free 
energy of histone octamer binding and directly influences the positioning of nucleosomes, which 
increases DNA unwrapping from the octamer [69]. Further, acetylation of K56 on histone H3 has 
been found to play important roles in transcriptional activation; deacetylation of K56 drives 
chromatin toward the assembled state and represses transcription [70]. In addition, acetylation 
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of K122 activates transcription, and the lack of it significantly impairs gene induction [71]. These 
observations point to the possibility that aspirin promotes acetylation at K56 and K122 globally, 
but at the EMT loci, it inhibits acetylation of the two lysine residues, thereby inhibiting the 
binding of transcription factors and repressing EMT genes. The reduced mRNA levels for α-
SMA, αB-crystallin and FN in TGFβ2- and aspirin-treated cells when compared to levels with 
treatment with TGFβ2 alone support this view. A previous study showed that TSA suppresses 
the TGFβ1-mediated EMT of human kidney tubular epithelial cells by acetylation of histone H3 
and H4 without exerting effects on the phosphorylation of Smad2 and Smad3 [50]. This is 
somewhat similar to our finding in this study that aspirin did not alter the TGFβ2-mediated 
phosphorylation of Smad2 and Smad3 but decreased acetylated histone H3 levels during 
inhibition of EMT of LECs. Further, aspirin could modulate the levels/activities of Smad 
transcriptional corepressors, such as TG-interacting factor (TGIF), Sloan-Kettering Institute (Ski), 
Ski-related novel gene (SnoN), or antagonists of TGFβ signaling, such as bone morphologic 
protein (BMP)-7, Smad6 or Smad7, during the inhibition of EMT, which needs to be investigated. 
 
Further evidence for the ability of aspirin to inhibit TGFβ2-mediated EMT came from our work on 
human lens capsular bags. Treatment with aspirin at a 2 mM concentration inhibited capsule 
wrinkling and α-SMA expression during the 28-day period of incubation, suggesting that chronic 
exposure to aspirin can block changes in the capsule that are integral to PCO. Our mouse 
experiments further validated the human capsule results. Initially, we administered 1 mg (10 
mg/ml, 100 μl) of aspirin through oral gavage once a day for 5 days and found that it had no 
effect on the acetylation of lens proteins (Supplementary Fig. 5). We then administered aspirin 
through drinking water and found that acetylation was occurring on lens proteins both in LECs 
and lens fiber cells. These results further reiterated the notion that chronic exposure to aspirin is 
required to acetylate lens proteins and inhibit EMT of LECs. 
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Lensectomy in mice has been used as a model for human PCO [72]. Epithelial cells on the 
capsule synthesize α-SMA in response to the wound created during lensectomy [42]. Although 
an IOL cannot be implanted in the mouse lens capsule bag, the capsular bag was filled with a 
viscoelastic material that prevented, to some extent, the collapse of the anterior and posterior 
capsules. Aspirin administration for 5 days prior to lensectomy and for 5 days post lensectomy 
inhibited α-SMA production in the LECs, a clear indication that aspirin can block EMT in 
lensectomized mice. 
 
Taken together, these results suggest that aspirin may block the EMT of LECs during PCO in 
humans. However, the concentration needed to realize the effect, at least in cell culture and 
mouse experiments, was 2 mM and 1 mg/ml in drinking water daily, respectively. Whether one 
can achieve such concentrations in the lens after cataract surgery remains to be determined. 
Many patients with cardiovascular complications or individuals intending to prophylactically 
prevent cardiovascular diseases take aspirin at 75 to 100 mg/day quantities [73]. It has been 
shown that 40 min after ingesting 100 mg of aspirin, the plasma concentration was 2.2 ± 1.6 
μg/ml, and with 1500 mg, it was 21.1± 8.9 μg/ml [74]. What portion of the ingested aspirin 
makes its way to the lens in humans is unclear. If sufficient aspirin reaches the LECs after 
cataract surgery, it could inhibit PCO development. It will be interesting to determine in a 
retrospective study whether the incidence of PCO or the need for YAG laser treatment is lower 
in chronic users of aspirin compared to those of nonusers and whether the effects, if any, 
correlate with the dosage of aspirin. 
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Figure legends 
Figure 1. Effect of aspirin on the cell viability, proliferation, and acetylation of cellular 
proteins. Cell viability and proliferation were measured by the MTT assay. (A) FHL124 cells 
were treated with varying concentrations of aspirin for 48 h in serum-free media and then 
incubated with MTT reagent for 4 h. (B) Cells were treated with varying concentrations of aspirin 
for 24 h in 5% FBS-containing media, followed by TGFβ2 treatment at 10 ng/ml for an additional 
24 h. The reversibility of acetylation was assessed by western blotting using acetyllysine 
antibody. (C) FHL124 cells were treated with 2 mM aspirin for 24 h or 48 h or treated with 
aspirin for 24 h and then incubated in serum-free medium for an additional 24 h. Lane 1, control; 
lane 2, aspirin-24 h; lane 3, aspirin-48 h; and lane 4, aspirin-24 h + serum-free medium for 24 h. 
(D) FHL124 cells were treated with 2 mM aspirin for 24 h and then incubated in 10 ng/ml TGFβ2 
for an additional 24 h in the presence or absence of aspirin. Lane 1, control; lane 2, TGFβ2-24 h; 
lane 3, aspirin-48 h; and lane 4, aspirin-24 h + TGFβ2-24 h. The data represent the mean ± SD 
of three independent experiments. **p<0.01, ***p<0.001, ****p<0.0001 compared to control cells 
(without any treatment). M=molecular weight markers (kDa). 
 
Figure 2. Effect of aspirin on TGFβ2-induced EMT, stress fiber formation and cell 
migration in FHL124 cells. (A) Cells were treated with 2 mM aspirin for 24 h, followed by 
TGFβ2 treatment at 10 ng/ml for an additional 24 h. Total cell lysates were probed for α-SMA, 
fibronectin (FN) and αB-crystallin by western blotting to measure protein levels. (B) Cells were 
treated with 2 mM aspirin for 24 h, followed by 10 ng/ml TGFβ2 treatment along with aspirin (2 
mM) for another 6 h. qRT-PCR was performed to determine the mRNA levels of α-SMA, FN and 
αB-crystallin. (C) Cells were fixed and immunostained for α-SMA (counterstained with DAPI). (D) 
F-actin was visualized using Texas Red-conjugated phalloidin. (E) Scratch assay images were 
captured at 4X magnification after a 24-h incubation with TGFβ2 with or without aspirin. (F) The 
migrated area was quantified as the total distance that the cells moved from the edge of the 
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scratch toward the center of the scratch. The values are normalized to control cells. The bars 
represent the mean ± SD of three independent experiments. ns= not significant, *p<0.05, 
**p<0.01. Scale bar, 50 μm. 
 
Figure 3. Halting effect of aspirin on TGFβ2-induced EMT. FHL124 cells were treated with 
10 ng/ml TGFβ2 for 24 h, and then 2 mM aspirin was added in the presence of TGFβ2 for an 
additional 24 h. Total cell lysates were subjected to western blotting to analyze the expression 
of α-SMA, FN and αB-crystallin. The values are normalized to control cells. The bars represent 
the mean ± SD of three independent experiments. ns= not significant, *p<0.05, **p<0.01. 
 
Figure 4. Effect of aspirin in the human capsular bag. Four series of match-paired 
experiments were performed. The first two series employed serum-free (SF) EMEM as the 
standard medium (A and B) while the final pair of match-paired comparisons utilized 5% FCS 
supplemented EMEM as the standard medium (C and D). Match-paired experiments compared 
capsular bags maintained in standard medium (SF EMEM or 5% FCS EMEM) ± 2 mM aspirin or 
involved the addition of 10 ng/ml TGFβ2 to each culture maintained in standard medium (SF 
EMEM or 5% FCS EMEM) ± 2 mM aspirin. (A) Low power modified dark field micrographs 
showing the coverage of the central posterior capsule (PC) i.e. within the rhexis margin, 
observed at the end-point (day 19). Preparations were maintained in serum-free EMEM as the 
standard culture medium. Higher magnification images show cells on the central PC. 
Quantitative data showing the percent coverage of the central PC under different culture 
treatments are also provided along with the quantitative assessment of matrix contraction in 
TGFβ2-treated preparations. (B) Representative fluorescence images captured at the end-point 
(day 19) showing the expression and distribution patterns of the EMT marker, α-SMA in cells 
growing on the central PC with serum-free EMEM as the standard medium. Nuclei were 
visualized using DAPI as a counterstain. Quantitative data showing the relative levels of α-SMA 
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under different culture treatments are also provided. (C) Low power modified dark field 
micrographs showing coverage of the central PC, i.e., within the rhexis margin, observed at the 
end-point (day 19). Preparations were maintained in 5% FCS EMEM as the standard culture 
medium. Higher magnification images show cells on the central posterior capsule. Quantitative 
data showing the percent coverage of the central PC under different culture treatments are also 
provided along with the quantitative assessment of matrix contraction in TGFβ2-treated 
preparations. (D) Representative fluorescence images captured at the end-point (day 19) 
showing the expression and distribution patterns of the EMT marker α-SMA in cells growing on 
the central PC with 5% FCS EMEM as the standard medium.  Nuclei were visualized using 
DAPI as a counterstain. Quantitative data showing the relative levels of α-SMA under different 
culture treatments are also provided. The bars represent the mean ± SD of three independent 
experiments. ns= not significant, *p<0.05, **p<0.01, ***p<0.001, ****p<0.0001. 
 
Figure 5. Effect of aspirin on the TGFβ2 signaling pathway. Western blot images show the 
effect of aspirin on canonical (A and B) and noncanonical (C) TGFβ2 signaling in FHL124 cells. 
FHL124 cells were incubated with 2 mM aspirin for 24 h, followed by 10 ng/ml TGFβ2 treatment 
for an additional 0.5 (A and C) or 2 h (B). Total cell lysates were subjected to western blotting to 
analyze the phosphorylation levels of each signaling pathway. The bars represent the mean ± 
SD of three independent experiments. ns= not significant, *p<0.05, ***p<0.001. 
 
Figure 6. Effect of aspirin on HDAC activity (A) and the acetylation of α-tubulin (B). 
FHL124 cells were incubated with 2 mM aspirin for 24 h, followed by 10 ng/ml TGFβ2 treatment 
for an additional 24 h. HDAC activity levels were determined in the nuclear and cytoplasmic 
fractions using a colorimetric assay kit. Protein levels of Ac-α-tubulin and β-actin were quantified 
by western blot analysis. The bars represent the mean ± SD of three independent experiments. 
ns= not significant, ***p<0.001. 
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Figure 7. Effect of aspirin on histone acetylation. Cells were treated with aspirin (2 mM) for 
24 h and then with aspirin (2 mM) with or without TGFβ2 (10 ng/ml) for an additional 6 h, and 
histones were extracted. (A) Total histones were fractionated by gel electrophoresis and stained 
with Coomassie blue (left), and the level of acetylation was determined by western blot analysis 
with anti-acetyllysine (right). (B) Acetylated histone H3 lysine residues were determined by 
western blot analysis. Bars represent the mean ± SD of three independent experiments. ns= not 
significant, *p<0.05, **p<0.01. M= molecular weight markers (kDa). 
 
Figure 8. Aspirin-induced histone acetylation regulates EMT-related gene transcription. 
FHL124 cells were incubated with 2 mM aspirin for 24 h, followed by 10 ng/ml TGFβ2 treatment 
for an additional 2 h in the presence of aspirin. ChIP assays were performed using specific 
antibodies against acH3K56 and acH3K122 or with normal rabbit IgG. Quantitative PCR was 
performed using specific primers for the promoter regions of ACTA2 (A) and COL1A1 (B). In 
control experiments in which naive rabbit IgG was used, there was very low amplification for 
ACTA2 and no amplification for COL1A1 (right panels in A and B). The relative DNA levels were 
normalized to the input chromatin. (C-D) After immunoprecipitation, total cell lysates were 
subjected to western blotting for Smad4. The bars represent the mean ± SD of three 
independent experiments. ns= not significant, *p<0.05, **p<0.01. 
 
Figure 9. Effect of aspirin on EMT in lensectomized mice. Mice were administered either 0.5 
mg/ml (n=3) or 1 mg/ml (n=4) of aspirin in drinking water for 5 days. Control mice were treated 
with 25 mM sodium phosphate buffer in drinking water. (n=3). (A) The level of acetylation in lens 
proteins was determined by western blot analysis with acetyllysine antibody. (B) Control and 1 
mg/ml aspirin-treated mouse lenses were immunostained with acetyllysine antibody. The insert 
was enlarged and is shown in the right panel. The arrowhead denotes the mouse LECs. (C) The 
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expression of α-SMA (red) on postoperative day 5. Mice were treated with aspirin or sodium 
salicylic acid (SA) for 5 days prior to the lensectomy and for 5 days thereafter. Collagen type IV 
(green) was used for the lens capsule marker. Nuclei were stained with DAPI (blue). The 
dashed line traces the lens capsule. The arrowhead denotes the anterior capsule, and the 
arrows denote the posterior capsule. N=3. Scale bar= 50 μm. 
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Supplementary Fig. 1. Effective concentration of aspirin in the cell culture medium. Aspirin was 
incubated in MEM with 5% FBS or without FBS (SF) for 48 h. Serum protein bound aspirin was 
removed by ultrafiltration using a 10 kDa filter, and then the concentration of aspirin was 
measured at 530 nm.  
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Supplementary Fig. 2. Effect of aspirin on cell proliferation. FHL124 cells were treated with 2 
mM of aspirin for 24 h, followed by 10 ng/ml TGFβ2 treatment for an additional 24 h. Cell were 
labeled with BrdU, fixed, permeabilized, and detected incorporated BrdU using anti-BrdU mouse 
monoclonal antibody (1:100 dilution, Santa Cruz Biotechnology, Cat# sc-56255). 
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Supplementary Fig. 3. Effect of salicylic acid on TGFβ2-induced α-SMA expression. FHL124 
cells were treated with 2 mM of either aspirin or sodium salicylic acid (SA) for 24 h, followed by 
10 ng/ml TGFβ2 treatment for an additional 24 h. Total cell lysates were subjected to western 
blotting to analyze the expression of α-SMA. 
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Supplementary Fig. 4. Effect of aspirin and TGFβ2 on protein acetylation. Western blot 
analysis of acetyllysine in total cell lysate (A), cytoplasmic and nuclear fractions (B). FHL124 
cells treated with aspirin at an indicated (A) or 2 mM (B) concentration for 24 h, followed by 10 
ng/ml TGFβ2 treatment for an additional 24 h. M=molecular weight markers (kDa). 
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Supplementary Fig. 5. Effect of aspirin on acetylation of mouse lens proteins. Mice were 
administered with 1 mg of aspirin in 100 µl of 25 mM sodium phosphate buffer through an oral 
gavage daily for 5 days. Control mice received 100 µl of 25 mM sodium phosphate buffer. Lens 
proteins were subjected to western blotting to analyze the acetyllysine. Ponceau S staining of 
the membranes served as the loading control. M=molecular weight markers (kDa). 
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Table 1. Primer sequences for qRT-PCR 
Gene Primer Sequence Experiment 
α-SMA 
(ACTA2) 
Forward 5′-TTCAATGTCCCAGCCATGTA-3′ 
qRT-PCR 
Reverse 5′-GAAGGAATAGCCACGCTCAG-3′ 
αB-
Crystallin 
(CRYAB) 
Forward 5′-CTTTGACCAGTTCTTCGGAG-3′ 
qRT-PCR 
Reverse 5′-CCTCAATCACATCTCCCAAC-3′ 
Fibronectin 
(FN1) 
Forward 5′-TTCGAGATCAGTGCATTGTTGAT-3′ 
qRT-PCR 
Reverse 5′-TCATGACGCTTGTGGAATGTG-3′ 
GAPDH 
Forward 5′-GTCAGTGGTGGACCTGACCT-3′ 
qRT-PCR 
Reverse 5′-TGCTGTAGCCAAATTCGTTG-3′ 
ACTA2 
Forward 5' CGGTAAACAAGCCTCCAGAAGC 3' 
ChIP 
Reverse 5' CAGCACCGAAGCAGTGGTTAAG 3' 
COL1A1 
Forward 5' AGGACAGTATAAAAGGGGCCCG 3' 
ChIP 
Reverse 5' TGTAGACTCTTTGTGGCTGGGG 3' 
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Table 2. Mass spectrometric identification of acetylation on histone H3 extracts. FHL124 
cells were treated with 2 mM aspirin for 24 h, followed by 10 ng/ml TGFβ2 treatment for an 
additional 24 h. Total histones were fractionated by gel electrophoresis, and the level of 
acetylation on histone H3 was determined by LC-MS/MS. 
Peptide 
index 
Sequence 
Acetylation 
Site 
Modifications identified by 
spectrum 
9 to 17 KSTGGKAPR K9 Acetyl (+42), Delta:H(4)C(2) (+28) 
27 to 36 KSTGGKAPR  K14 
Oxidation (+16), Carbamidomethyl 
(+57), Acetyl (+42) 
27 to 40 KSAPATGGVK  K27 Acetyl (+42), Delta:H(4)C(2) (+28) 
54 to 63 YQKSTELLIR K56 Acetyl (+42) 
73 to 83 EIAQDFKTDLR K79 Acetyl (+42) 
84 to 115 
FQSSAVMALQEASEAYLV
GLFEDTNLCAIHAK 
K115 
Oxidation (+16), Carbamidomethyl 
(+57), Acetyl (+42) 
117 to 128 VTIMPKDIQLAR K122 Oxidation (+16), Acetyl (+42) 
 
K9 K14 K27 K56 K79 K115 K122 
Control ■ ■ ■ 
 
■ ■ 
 
Aspirin ■ ■ ■ ■ ■ ■ ■ 
TGFβ2 ■ ■ ■ 
 
■ 
  
Aspirin + TGFβ2 ■ ■ ■ ■ ■ ■ ■ 
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